NASDAQ:MCAD Mountain Crest Acquisition Corp. II (MCAD) Stock Price, News & Analysis → NYSE Spotlight & A Soaring Biotech Breakthrough You Need to See (From PharmaStocksToday) (Ad) Free MCAD Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.0120▼$0.015050-Day Range$4.78▼$10.9752-Week Range$8.50▼$12.99Volume43,217 shsAverage Volume74,637 shsMarket Capitalization$98,241.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media Get Mountain Crest Acquisition Corp. II alerts: Email Address Ad DTIthe harsh reality of the stock marketOK, you’re not supposed to say this In fact, maverick investor Graham Lindman says it’s become the silent elephant in the room that everyone is pretending isn’t there. But he just said it: Most stocks suck. And he isn’t saying that figuratively or subjectively… You see, 96% of stocks underperform. Just 4% of “Apex Stocks” generate virtually all the wealth.All you have to do is watch here for all the details. About Mountain Crest Acquisition Corp. IIMountain Crest Acquisition Corp. II. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.Read More Ad DTIthe harsh reality of the stock marketOK, you’re not supposed to say this In fact, maverick investor Graham Lindman says it’s become the silent elephant in the room that everyone is pretending isn’t there. But he just said it: Most stocks suck. And he isn’t saying that figuratively or subjectively… You see, 96% of stocks underperform. Just 4% of “Apex Stocks” generate virtually all the wealth.All you have to do is watch here for all the details. MCAD Stock News HeadlinesOctober 27, 2021 | apnews.comMountain Crest Acquisition Corp. II Stockholders Approve Business Combination with Better ...October 27, 2021 | finance.yahoo.comMountain Crest Acquisition Corp. II Stockholders Approve Business Combination with Better Therapeutics Inc.April 30, 2024 | American Hartford Gold Group (Ad)Rich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.October 26, 2021 | finance.yahoo.comMountain Crest Acquisition Corp. II and Better Therapeutics, Inc. Announce Registration Statement Effectiveness and Scheduled Special Meeting to Approve Business Combination on October 27, 2021See More Headlines Receive MCAD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mountain Crest Acquisition Corp. II and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/30/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health Services Sub-IndustryN/A Current SymbolNASDAQ:MCAD CUSIPN/A CIK1832415 Webmcacquisition.com Phone646-493-6558FaxN/AEmployees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio3.66 Quick Ratio3.66 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.02 per share Price / Book0.65Miscellaneous Outstanding Shares7,557,000Free FloatN/AMarket Cap$98,241.00 OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesDr. Suying Liu (Age 33)Chairman & CEO Mr. Dong Liu (Age 35)CFO & Director Key CompetitorsIgnyte AcquisitionNASDAQ:IGNYStatera BiopharmaNASDAQ:STABBruush Oral CareNASDAQ:BRSHHumanigenNASDAQ:HGENScopus BioPharmaNASDAQ:SCPSView All Competitors This page (NASDAQ:MCAD) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersThe Gold Grab of the CenturyColonial MetalsProtect Your Bank Account Before It’s Too LateWeiss RatingsTrump’s last act as President Porter & CompanyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsIs Tesla going out of business?DTIElon Musk Secret Crypto Plot ExposedCrypto 101 MediaHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceREAD THIS – If You Missed Out On The AI BoomBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mountain Crest Acquisition Corp. II Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.